IGFBP3 and Huntington disease: There were no associations between the risk of death in HD patients and the other analyzed SNVs (FOXO3 rs2802292; IGF2BP2 rs4402960, and rs11705701; IGFBP3 rs3110697, and rs2854744; FABP1 rs2241883, and rs2919872; PCSK9 rs562556, and rs11206510; and DOCK6 rs17699089) (Tables S7–S12).